Amrize Ltd
AMRZ· NYSE
AMRZAmrize Ltd
Filed Aug 7, 2025 · 10-Q · 38 days after period end · 0002035989-25-000004
| Metric | Q2 2025 | Q2 2024 |
|---|---|---|
| Revenue | $3.22B | $3.24B |
| Net Income | $417.00M | $474.00M |
| EPS Diluted | $0.75 | $0.86 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Amrize Ltd · CIK 2035989 · Engraved from SEC EDGAR
ended Jun 30, 2025 · filed Aug 7, 2025 · 38 d after period end
